Skip to main content
. 2017 Dec 13;29(12):2228–2235. doi: 10.1589/jpts.29.2228

Table 3. Treatment outcomes according to the WOMAC pain subscale.

Study Intervention Mean difference % Change from baseline Effect size MCII achieved

Pre-treatment
(SD)
12-month
Post-treatment
(SD) except ¶
Between
groups
Somers et al., 201220) PCST +BWM 47.7 (22.5) 27.2 (13.05) −20.5 −43% 0.77$ Yes
PCST only 42.8 (20.16) 34.5 (14.62) −8.3 −19.4% 0.25 No
BWM only 42.6 (19.2) 35.5 (13.9) −0.71 −16.7% 0.18 No
Standard care* 43.3 (22.04) 38.0 (14.03) −5.3 −12.2% - No

Helminen et al., 201418) CBT 57.6 (13.4) 35.6 (20.2) −22 −38.2% 0.18 Yes
GP care* 56.4 (13.6) 39.5 (22.0) −16.9 −30% - No

Smith et al., 201530) CBT-I 46.5 (20) 40.3 (23.8) ¶ −6.2 −13.3% 0.18 No
BD* 49.7 (24.5) 35.4 (27.5) ¶ −14.3 −28.8% - No

Bennell et al., 201619) PCST +exercise 45 (14) 26 (16.5) −19 −42.2% 0.06 Yes
PCST only 43.5 (14) 29 (15) −14.5 −33% 0.12 No
Exercise only* 43 (13.5) 27 (17) −16 −37.2% - No

Mean difference score calculated according to (0–100) scale. MICC: Minimally Clinically Important Improvement in WOMAC pain subscale [−40.8% or −19.9 scale]; ¶ Post-treatment average after 6-month follow-up time point; * Control group for effect size; $ considered a >0.75 moderate to large effect; WOMAC: the Western Ontario and McMaster Universities osteoarthritis index; PCST: Pain Coping Skills Training; BWM: Behavioural Wight Management; CBT: Cognitive Behavioural Therapy; CBT-I: Cognitive Behavioural Therapy For Insomnia; BD: Behavioural desensitization; CMD: Clinically meaningful difference.